研究者詳細 - 馬場　健児

論文 - 馬場　健児

分割表示 142 件中 61 - 80 件目／全件表示 >>

胎児先天性心疾患症例への産科医、小児循環器科医の関わりと倫理的配慮

衛藤英理子, 三島桜子, 大平安希子, 谷和祐, 牧尉太, 光井崇, 早田桂, 増山寿, 近藤麻衣子, 馬場健児

超音波医学 47 ( Suppl. ) S363 - S363 2020年11月

Outcomes of Patients with Pulmonary Atresia with Intact Ventricular Septum Reaching Adulthood 査読

Norihisa Toh, Yasuhiro Kotani, Teiji Akagi, Yosuke Kuroko, Kenji Baba, Shin-ichi Otsuki, Shingo Kasahara, Hiroshi Ito

CONGENITAL HEART DISEASE 15 ( 1 ) 1 - 12 2020年6月

記述言語：英語掲載種別：研究論文（学術雑誌）出版者・発行元：TECH SCIENCE PRESS

Background: There is limited information on outcomes of adult patients with pulmonary atresia with intact ventricular septum (PA-IVS) due to the low incidence of disease and the large variation of surgical histories. Methods: Among 58 patients with repaired PA-IVS, a total of 32 patients aged >= 16 years and who were followed at our institution between January 2003 and December 2018 were reviewed. Surgical history, clinical outcomes, and laboratory, echocardiographic and electrocardiographic data were obtained by chart review. Results: Follow-up was from the age of 16 years and the median age at the latest follow-up was 23.7 years. Twenty-four patients had undergone biventricular repair (BVR), 3 had undergone one-and-a half ventricular repair (1.5VR), and 5 had undergone univentricular repair. Over a median follow-up period of 7.7 years (interquartile range: 4.1-11.0 years), 1 BVR patient died suddenly and 7 patients had heart failure. Arrhythmias were present in 5 patients. Ten patients underwent surgical re-interventions, including 4 BVR take-downs with conversion to 1.5VR and 3 Fontan conversions. Overall survival, heart failure-free, arrhythmia-free, and surgical re-intervention-free rates at 5 years and 10 years from the age of 16 years were 96.2% (95% confidence interval [CI], 77.2-99.4) and 96.2% (95% CI, 77.2-99.4), 81.4% (95% CI, 62.1-92.1) and 74.6% (95%CI, 52.3-88.7), 88.7% (95% CI, 70.1-96.3) and 75.9% (95% CI, 51.7-90.2), and 80.7% (95% CI, 60.8-91.8) and 70.8% (95% CI, 49.7-85.7), respectively. Conclusion: Adults with PA-IVS have preserved long-term survival regardless of the early operative strategy, while they are at risk for heart failure, arrhythmia, and surgical re-intervention. Thus, detailed and continued follow-up is mandatory for all PA-IVS patients from childhood to adulthood.

DOI： 10.32604/CHD.2020.011579

Web of Science

researchmap

Embolization using hydrogel-coated coils for pulmonary arteriovenous malformations 査読

T. Iguchi, T. Hiraki, Y. Matsui, H. Fujiwara, J. Sakurai, K. Baba, S. Toyooka, H. Gobara, S. Kanazawa

Diagnostic and Interventional Imaging 101 ( 3 ) 129 - 135 2020年3月

記述言語：英語掲載種別：研究論文（学術雑誌）

Purpose: To prospectively evaluate the efficacy and safety of embolization using hydrogel-coated coils for the treatment of pulmonary arteriovenous malformations (PAVMs). Materials and methods: The outcomes of 21 PAVMs in 19 patients (3 men and 16 women; mean age, 58.8 ± 15.2 [SD] years; age range 14–78 years) treated by venous sac embolization (VSE) with additional feeding artery embolization were prospectively evaluated. For VSE, using one or more 0.018-inch hydrogel-coated coils was mandatory. Recanalization and/or reperfusion were evaluated by pulmonary arteriography 1 year after embolization. Results: The mean feeding artery and venous sac sizes were 4.0 mm and 8.5 mm, respectively. Embolization was successfully completed in 20/21 PAVMs, yielding a technical success rate of 95%. The feeding artery was also embolized in 17/20 successful PAVMs (85%). A technical failure occurred in one PAVM, where embolization was abandoned because of migration of one bare coil to the left ventricle. The mean numbers of hydrogel-coated coils and bare platinum detachable coils used for VSE were 3.3 ± 2.1 (SD) (range, 1–8) and 4.4 ± 3.9 (SD) (range, 1–17), respectively. The mean percentages of hydrogel-coated coils in number, length, and estimated volume were 42.9%, 33.3%, and 72.7% respectively. One patient with one PAVM was lost to follow-up after 3 months. Neither recanalization nor reperfusion was noted in the remaining 19 PAVMs (success rate, 19/19 [100%]). One grade 4 (coil migration) adverse event occurred, and it was treated without any sequelae. Conclusion: VSE using hydrogel-coated coils with additional feeding artery embolization is a safe and effective treatment for PAVM.

DOI： 10.1016/j.diii.2019.10.008

Scopus

PubMed

researchmap

タンパク漏出性腸症を伴った心疾患の成人期の予後(Clinical outcomes of adult congenital heart disease patients with protein losing enteropathy)

杜徳尚, 小谷恭弘, 赤木禎治, 横濱ふみ, 黒子洋介, 馬場健児, 大月審一, 笠原真悟, 伊藤浩

日本成人先天性心疾患学会雑誌 9 ( 1 ) 248 - 248 2020年1月

Fontan患者におけるカテーテルアブレーション(Catheter ablation in Fontan patients)

西井伸洋, 森本芳正, 木村朋生, 宮本真和, 杜徳尚, 中川晃志, 渡邊敦之, 森田宏, 伊藤浩, 重光祐輔, 栄徳隆裕, 馬場健児, 笠原慎吾

日本成人先天性心疾患学会雑誌 9 ( 1 ) 223 - 223 2020年1月

Clinical outcomes after the endovascular treatments of pulmonary vein stenosis in patients with congenital heart disease 査読

Yoshihiko Kurita, Kenji Baba, Maiko Kondo, Takahiro Eitoku, Shingo Kasahara, Tatsuo Iwasaki, Shinichi Ohtsuki, Hirokazu Tsukahara

Cardiology in the Young 29 ( 8 ) 1057 - 1065 2019年8月

担当区分：責任著者記述言語：英語掲載種別：研究論文（学術雑誌）出版者・発行元：Cambridge University Press (CUP)

Abstract

Background:

Pulmonary vein stenosis (PVS) is a condition with challenging treatment and leads to severe cardiac failure and pulmonary hypertension. Despite aggressive surgical or catheter-based intervention, the prognosis of PVS is unsatisfactory. This study aimed to assess the prognosis and to establish appropriate treatment strategies.

Methods:

We retrospectively reviewed endovascular treatments for PVS (2001–2017) from the clinical database at the Okayama University Hospital.

Results:

A total of 24 patients underwent PVS associated with total anomalous pulmonary venous connection and 7 patients underwent isolated congenital PVS. In total, 53 stenotic pulmonary veins were subjected to endovascular treatments; 40 of them were stented by hybrid (29) and percutaneous procedures (11) (bare-metal stent, n = 34; drug-eluting stent, n = 9). Stent size of hybrid stenting was larger than percutaneous stenting. Median follow-up duration from the onset of PVS was 24 months (4–134 months). Survival rate was 71 and 49% at 1 and 5 years, respectively. There was no statistically significant difference between stent placement and survival; however, patients who underwent bare-metal stent implantation had statistically better survival than those who underwent drug-eluting stent implantation or balloon angioplasty. Early onset of stenosis, timing of stenting, and small vessel diameter of pulmonary vein before stenting were considered as risk factors for in-stent restenosis. Freedom from re-intervention was 50 and 26% at 1 and 2 years.

Conclusions:

To improve survival and stent patency, implantation of large stent is important. However, re-intervention after stenting is also significant to obtain good outcome.

DOI： 10.1017/s1047951119001495

researchmap

右室流出路再建術におけるContegraとYamagishi conduitの遠隔成績比較

平井健太, 馬場健児, 近藤麻衣子, 栄徳隆裕, 今井祐喜, 福嶋遥佑, 重光祐輔, 原真祐子, 小谷恭弘, 笠原真悟, 大月審一

日本小児循環器学会雑誌 35 ( Suppl.1 ) s1 - 225 2019年6月

胎児期から当院で管理した抗SS-A抗体による先天性完全房室ブロック症例の臨床経過

近藤麻衣子, 馬場健児, 栄徳隆裕, 今井祐喜, 重光祐輔, 福嶋遥佑, 平井健太, 原真佑子, 大月審一, 笠原真悟, 岩崎達雄

日本小児循環器学会雑誌 35 ( Suppl.1 ) s1 - 198 2019年6月

当施設におけるCRTの有用性の検討

重光祐輔, 大月審一, 馬場健児, 近藤麻衣子, 栄徳隆裕, 今井祐喜, 福嶋遥佑, 平井健太, 原真祐子, 小林優, 笠原真悟

日本小児循環器学会雑誌 35 ( Suppl.1 ) s1 - 106 2019年6月

機能的単心室TCPC手術・術後のFontan routeに対して修正・介入を行った症例の検討

福嶋遥佑, 大月審一, 馬場健児, 近藤麻衣子, 栄徳隆裕, 今井祐喜, 重光祐輔, 平井健太, 原真祐子, 笠原真悟, 岩崎達雄

日本小児循環器学会雑誌 35 ( Suppl.1 ) s1 - 201 2019年6月

有意なVSD、LVOTSのない修正大血管転位症のunnatural course

今井祐喜, 大月審一, 馬場健児, 近藤麻衣子, 栄徳隆裕, 重光祐輔, 福嶋遥佑, 平井健太, 原真祐子, 小林優

日本小児循環器学会雑誌 35 ( Suppl.1 ) s1 - 289 2019年6月

大動脈離断症の左室流出路狭窄に対する二心室修復適応

今井祐喜, 大月審一, 馬場健児, 近藤麻衣子, 栄徳隆裕, 重光祐輔, 福嶋遥佑, 平井健太, 原真祐子, 小林優

日本小児循環器学会雑誌 35 ( Suppl.1 ) s1 - 332 2019年6月

左室内非同期と心室間非同期を伴い、左室駆出率が低下したB型顕性WPW症候群にカテーテルアブレーションを行なうと、心機能が回復する

栄徳隆裕, 大月審一, 馬場健児, 近藤麻衣子, 今井祐喜, 福嶋遥佑, 重光祐輔, 平井健太, 小林優

日本小児循環器学会雑誌 35 ( Suppl.1 ) s1 - 105 2019年6月

この症例をどうするか?:カテーテル治療近接する左上下肺静脈狭窄に対してfenestration stent経由でstent留置を施行したフォンタン術後症例

馬場健児, 近藤麻衣子, 栄徳隆裕, 今井祐喜, 重光祐輔, 福嶋遥佑, 平井健太, 原真祐子, 大月審一

日本小児循環器学会雑誌 35 ( Suppl.1 ) s1 - 149 2019年6月

Balloon atrial septostomy in hypoplastic left heart syndrome with restrictive atrial septum

Yosuke Fukushima, Kenji Baba, Maiko Kondo, Yoshihiko Kurita, Takahiro Eitoku, Yusuke Shigemitsu, Kenta Hirai, Hirokazu Tsukahara, Tatsuo Iwasaki, Shingo Kasahara, Yasuhiro Kotani, Shinichi Otsuki

PEDIATRICS INTERNATIONAL 61 ( 4 ) 339 - 344 2019年4月

記述言語：英語掲載種別：研究論文（学術雑誌）出版者・発行元：WILEY

BackgroundRashkind balloon atrial septostomy (BAS) can be challenging in infants with hypoplastic left heart syndrome (HLHS) and small atrial septal defect (ASD).MethodsWe retrospectively reviewed all infants with HLHS who underwent surgery and BAS between January 2006 and December 2015. The infants were divided into three groups: no BAS; catheter BAS; and open AS. Infants who underwent catheter BAS were divided into two groups based on atrial septal anatomy: standard and complex.ResultsOf the 70 patients, 57 (81%) underwent Glenn surgery. Subsequently, a significant difference in survival was observed: 86% (44/51), 91% (10/11), and 25% (2/8) in the no BAS, catheter BAS, and open AS groups, respectively (P = 0.0002). No significant difference was seen between the no BAS and the catheter BAS groups (P = 1.0). In the 56 patients who underwent catheterization after surgery, no intergroup differences in mean pulmonary artery pressure, pulmonary vascular resistance, or pulmonary artery index were found. We classified catheter BAS into standard (n = 5) and complex (n = 5) based on ASD location, and septum thickness. All patients in the standard group underwent complete Rashkind BAS, but in the complex group, only one patient underwent complete Rashkind BAS, with the remaining requiring initial static BAS (P = 0.048). Following septostomy, ASD size, ASD flow, and percutaneous oxygen saturation (SpO(2)) were not significantly different between the two groups.ConclusionsCatheter BAS is effective in infants with HLHS and a restrictive atrial septum. Infants with standard or complex atrial septum can achieve equivalent outcomes despite more patients often requiring static BAS.

DOI： 10.1111/ped.13716

Web of Science

researchmap

エブスタイン奇形成人臨床経過および心血管イベントの予測因子(Adults with Ebstein Anomaly: Clinical Course and Predictors of Cardiovascular Events)

杜徳尚, 赤木禎治, 小谷恭弘, 横濱ふみ, 高橋生, 黒子洋介, 馬場健児, 大月審一, 笠原真悟, 伊藤浩

日本循環器学会学術集会抄録集 83回 OJ29 - 8 2019年3月

A Clinical Survey on Current Status of Ductal Stenting in Congenital Heart Disease in Japan 査読

Journal of Pediatric and Cardiac Surgery 3 ( 1 ) 1 - 7 2019年1月

Ebstein病の中長期予後についての検討(Mid-term clinical outcomes in adult patients with surgically operated Ebstein anomaly)

杜徳尚, 赤木禎治, 小谷恭弘, 横濱ふみ, 黒子洋介, 馬場健児, 大月審一, 笠原真悟, 伊藤浩

日本成人先天性心疾患学会雑誌 8 ( 1 ) 104 - 104 2019年1月

ファロー四徴症術後の小児期の肺動脈弁逆流および狭窄が、成人期の右室サイズに与える影響についての検討

杜徳尚, 小谷恭弘, 赤木禎治, 高橋生, 黒子洋介, 馬場健児, 大月審一, 笠原真悟, 伊藤浩

日本心臓病学会学術集会抄録 66回 O - 017 2018年9月

Prenatal diagnosis of a huge ventriculocoronary fistula in pulmonary atresia with intact ventricular septum. 査読

Kondo M, Baba K, Kurita Y, Eitoku T, Shigemitsu Y, Fukushima Y, Hirai K, Kasahara S, Iwasaki T, Ohtsuki S.

Journal of Pediatric Cardiology and Cardiac Surgery 2 99 - 100 2018年7月

　前のページ - 次のページ　

<馬場 健児>

論文 - 馬場 健児

<馬場　健児>

論文 - 馬場　健児